12/13/2024 7:47 PM | JONAS JEFFREY M (Reporting) Sage Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 3:42 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2024 5:40 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 5:14 PM | BB BIOTECH AG (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024 3:56 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024 1:17 PM | BlackRock, Inc. (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
|
11/04/2024 2:28 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 1:10 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024 3:23 PM | Sage Therapeutics (Issuer) Shiferman Gregory L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/01/2024 3:24 PM | Sage Therapeutics (Issuer) Shiferman Gregory L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 3:10 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 3:20 PM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024 10:37 AM | Sage Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024 6:11 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 5:37 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2024 6:07 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 5:33 AM | Sage Therapeutics (Filer)
| Form S-3ASR | |
07/31/2024 3:10 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2024 3:15 PM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 5:39 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 3:57 PM | Federer Jessica (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:57 PM | Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:57 PM | COLA MICHAEL F (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | Germano Geno J (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | Golumbeski George (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:58 PM | JONAS JEFFREY M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 11:15 AM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
06/10/2024 8:48 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2024 8:54 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/25/2024 6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 5:46 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024 7:31 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 5:35 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2024 7:34 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 6:49 AM | Sage Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
How this >10-cent coin is going to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2024 |
02/14/2024 6:20 AM | Sage Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:09 AM | RTW INVESTMENTS, LP (Filed by) Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:13 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024 5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 5:28 AM | BB BIOTECH AG (Filed by) BB BIOTECH AG (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 9:17 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024 4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024 3:50 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 9:04 AM | Sage Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:07 PM | IGUCHI KIMI (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Golumbeski George (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | PAUL STEVEN M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Federer Jessica (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023 7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |